![](/sites/default/files/centre/fleming%20Fund.jpg)
In response to the global threat of anti-microbial resistance (AMR) the Fleming Fund was established in 2015 to assist low and middle-income countries (LMIC) in developing surveillance systems and laboratory capacity. CCR conducted three initial complementary scoping studies to help funding partners identify areas of greatest need and how best to strengthen surveillance capacity.